<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>brilabuskes</author_name><author_url>https://kffhealthnews.org/news/author/brilabuskes/</author_url><title>Pharma's Defeat In Doughnut Hole Battle Possible Harbinger Of Things To Come For Powerful Industry - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="6INKkHQ6cb"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/pharmas-defeat-in-doughnut-hole-battle-possible-harbinger-of-things-to-come-for-powerful-industry/"&gt;Pharma&#x2019;s Defeat In Doughnut Hole Battle Possible Harbinger Of Things To Come For Powerful Industry&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/pharmas-defeat-in-doughnut-hole-battle-possible-harbinger-of-things-to-come-for-powerful-industry/embed/#?secret=6INKkHQ6cb" width="600" height="338" title="&#x201C;Pharma&#x2019;s Defeat In Doughnut Hole Battle Possible Harbinger Of Things To Come For Powerful Industry&#x201D; &#x2014; KFF Health News" data-secret="6INKkHQ6cb" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>Despite an intense lobbying push, drugmakers weren't able to convince lawmakers to let them off the hook for beneficiaries that fall into the doughnut hole, raising questions about the industry's current clout. Meanwhile, a drug distributor has been accused of illegally pooling leftover cancer medications to sell to providers; Norvatis is buying gene-therapy company AveXis; a powerful pharmaceutical company dabbles in vineyards; and more.</description></oembed>
